Stem/Progenitor Cells and Pulmonary Arterial Hypertension

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Pulmonary Medicine

Background:

• Pulmonary arterial hypertension (PAH) is a progressive vasculopathy characterized by endothelial dysfunction and vascular remodeling.
• Despite advancements, PAH treatments are limited, and prognosis remains poor.
• PAH pathogenesis involves complex cellular and molecular pathways, including growth factors, cytokines, and proteases.

Purpose of the Study:

• To review recent research on pulmonary arterial hypertension (PAH) pathogenesis.
• To focus on the role of stem/progenitor cells in PAH lesion formation.
• To highlight the potential of stem cell-based therapy for PAH.

Main Methods:

• Review of current scientific literature on PAH.
• Analysis of preclinical studies on stem/progenitor cell function in vascular repair.
• Synthesis of evidence on stem/progenitor cell contributions to PAH development.

Main Results:

• Stem/progenitor cells demonstrate potential in promoting endothelial repair and neovascularization in preclinical models.
• Emerging evidence implicates stem/progenitor cells in the development of vascular lesions in PAH.
• Stem/progenitor cells influence vascular cell functions relevant to PAH pathogenesis.

Conclusions:

• Stem/progenitor cells represent a significant area of investigation for PAH therapy.
• Understanding stem/progenitor cell roles in PAH pathogenesis is crucial for developing novel treatments.
• Stem cell-based therapies hold potential for clinical application in managing pulmonary arterial hypertension.